- Responsible for all financial, accounting and administrative aspects (including IT) of the iQone group including: statutory accounting for each subsidiary and consolidated accounting for the group, budgets/financial analysis/planning and modeling of the profit and loss account, cash flow forecasts, cash flow, and working capital monitoring. - Finance Business Partner for the rest of the Executive Committee (in particular the CEO and the COO). Interacts with the banks and accountancy firms in different countries (CH, FR, DE, IT, ES). - Oversaw the integration with the Clinigen Finance processes and team (10/2018 to 12/2021).- Supervised several people including a financial analyst based in Switzerland and an administrative and financial manager based in France.Achieved the following results: - Implemented and maintained a 7-year business plan and cash flow forecast (2016-2021)- Implemented a sales budgeting and forecasting process + weekly analysis of sales and receipts by customer (2016-2021)- Structured the quarterly accounting closing and purchase-to-pay processes (2016-2018)- Implemented IFRS for the group (2017-2018)- Implemented the change of accounting firms for the entire group from local accounting firms to BDO in all countries as a unified accounting partner (2017-2018)- Implemented the finance module of an ERP (Sage X3) as a unified group accounting tool (2017-2018)- Implemented a new IT support model for all group employees (2017)- Oversaw the change from quarterly to monthly closing on the day6 (2019)- Supervised the IT aspects of the name change from Iqone to Clinigen (2020)Worked in 2018 on - the financial aspects of a partnership between Iqone and Mepha regarding the joint marketing of Remsima in Switzerland - the acquisition of the iQone group by the Clinigen group: preparation of the acquisition accounts and the data room, interactions with Clinigen's financial advisors, structuring of the transaction on tax aspects

Team leader for International R&D Finance. Reporting to VP of R&D Finance, I supervise 3 employees over 3 locations in the UK and Germany. I am the head of Finance for the Amgen Research Munich entity (member of the management team, business partner of the Managing Director and the departments heads/Budget owners). I am the point of contact for R&D Finance outside the US.

Finance Business Partner for Development in Europe (Study Management, Study Operations, Feasibility, Biostats, Scientific Affairs, Therapeutic Areas, Observational Research). Drive the budget process = defining OPEX (by function) and Direct Outside Expenses (by product) targets, ensuring proper prioritization of activities across the portfolio, preparing budget review decks for Regional and Global R&D leaders, coordinating the Budget process with our US-based R&D colleagues. Leader of a cross-functional team of 15 (Finance and Program Management). Ensure accurate quarterly and year-end OPEX landing by providing financial information to my clients (data and explanations). Advisor to enable financial trade-offs.Finance representative in different projects incl. Country Footprint Rationalization (where I created a Net Present Value model for the project). I also validated the savings calculation model for a contract worker rate renegotiation project across 23 countries. Super-user during the implementation of the “Oracle Hyperion” planning and reporting solution.

Monitoring P&L (sales, OPEX et profitability) of the affiliate. Part of the Management Team. Business partner of the General Manager and the departments heads/Budget owners. Lead the implementation of a contract management & pricing system in 2011.

Planning and Analysis of Operating Expenses for Amgen n.v., the Belgian affiliate of Amgen Inc.- Leading budget process, preparing budget and forecasts- Monthly monthly management reports and ad-hoc analyses- Monthly accrual preparation- Prepared business and budget review - Procurement missions US GAAP context.

Risk assessments/analysis and audits of both design and operating effectiveness of controls. Compliance, financial, operational and SOX Audits.

Performance of independent business reviews (IBR), building of business plans, financial and/or operational restructuring, financial due diligences, assistance to French receivership

Audit specialized in manufacturing companies. Statutory and consolidated accounting, financial analysis. External audit of Renault and Wendel Investissement

Financial and tax analyses (including VAT) and project management in a multi-cultural context (Euro conversion).